Pages that link to "Q52101137"
Jump to navigation
Jump to search
The following pages link to Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. (Q52101137):
Displaying 50 items.
- The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project (Q21261508) (← links)
- Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease (Q28191187) (← links)
- Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia (Q33619754) (← links)
- A “bridging” (safety/tolerance) study of Besipirdine Hydrochloride in patients with Alzheimer's disease (Q34305358) (← links)
- Early neurone loss in Alzheimer's disease: cortical or subcortical? (Q35176873) (← links)
- Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease. (Q37634353) (← links)
- Opioid system and Alzheimer's disease (Q38004941) (← links)
- Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease (Q38596419) (← links)
- Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system (Q38770352) (← links)
- Neurobiological studies of transmitter systems in aging and in Alzheimer-type dementia (Q39428804) (← links)
- Brain and CSF somatostatin concentrations in patients with psychiatric or neurological illness. An overview (Q39472153) (← links)
- Dementia in movement disorders. (Q39480484) (← links)
- Amine accumulation in Parkinson's disease and other disorders (Q39481729) (← links)
- The nucleus basalis of Meynert in neurological dementing disease: a review (Q39483754) (← links)
- The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease (Q39765984) (← links)
- Neurotransmitter deficits in Alzheimer's disease: criteria for significance (Q40089993) (← links)
- The neurochemistry of Alzheimer's disease and senile dementia (Q40091112) (← links)
- The locus coeruleus and its possible role in ageing and degenerative disease of the human central nervous system (Q40116322) (← links)
- Pharmacotherapy of cognitive impairment in Alzheimer's disease: a review (Q40552135) (← links)
- The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems (Q40861115) (← links)
- Evidence for decreased transport of PNMT protein in advanced Alzheimer's disease (Q41213481) (← links)
- Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease (Q41317848) (← links)
- Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls (Q41635093) (← links)
- The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type (Q41775105) (← links)
- Rational drug treatment of dementia? (Q41947934) (← links)
- A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease (Q42150542) (← links)
- Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease (Q42453090) (← links)
- Alzheimer's disease and aluminum toxicology (Q42715786) (← links)
- Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia (Q44024789) (← links)
- Selective deficits in Alzheimer and parkinsonian dementia: visuospatial function (Q44156425) (← links)
- Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients (Q44983994) (← links)
- Evidence for decreased transport of tryptophan hydroxylase in Alzheimer's disease (Q45310068) (← links)
- Animal models of Alzheimer's disease: behavior, pharmacology, transplants. (Q48284797) (← links)
- Increased activity of surviving locus ceruleus neurons in Alzheimer's disease (Q48302893) (← links)
- Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease (Q48373983) (← links)
- Locus coeruleus as a target for psychogeriatric agents (Q48578563) (← links)
- Changes in neuropeptide expression in mice infected with prions (Q48580579) (← links)
- Catecholamine neurons with Alzheimer's neurofibrillary changes and alteration of tyrosine hydroxylase. Immunohistochemical investigation of tyrosine hydroxylase (Q48585201) (← links)
- Risk factors for neuroleptic-induced movement disorders (Q48620261) (← links)
- Dopamine-β-hydroxylase and acetylcholinesterase activities of cerebrospinal fluid in Alzheimer's disease (Q48654282) (← links)
- Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus (Q48662667) (← links)
- Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes (Q48679838) (← links)
- Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases (Q48701471) (← links)
- Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome (Q48713477) (← links)
- Neuropathology of the locus ceruleus: a semi-quantitative study (Q48850504) (← links)
- Neurotransmitter and Neuropeptide Systems in Alzheimer-Type Dementia (Q49116134) (← links)
- Neurochemistry of Alzheimer’s Disease: An Update (Q49123350) (← links)
- Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer's disease (Q49159546) (← links)
- Spatial shifts in visual attention in normal ageing and dementia of the Alzheimer type. (Q52115350) (← links)
- Effects of muscarinic and adrenergic agonism on auditory P300 in the macaque. (Q52165419) (← links)